{"id":105617,"date":"2026-05-28T08:00:00","date_gmt":"2026-05-28T06:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/?p=105617"},"modified":"2026-05-26T09:34:34","modified_gmt":"2026-05-26T07:34:34","slug":"pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients","status":"publish","type":"post","link":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/","title":{"rendered":"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0"},"content":{"rendered":"<p class=\"heading-para wp-block-paragraph\"><em>Par Sandra Silvestri, pour Ipsen.com<\/em>\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0<br>Chez Ipsen, nous nous engageons\u00a0\u00e0\u00a0explorer les questions encore sans r\u00e9ponse et\u00a0\u00e0\u00a0produire des donn\u00e9es robustes\u00a0qui vont\u00a0au\u2011del\u00e0\u00a0du d\u00e9veloppement\u00a0initial\u00a0du m\u00e9dicament, afin d\u2019apporter une vision\u00a0plus large et\u00a0\u00e0 long terme, fond\u00e9e sur des preuves,\u00a0au service des\u00a0communaut\u00e9s que nous\u00a0accompagnons.\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\"><strong>Le r\u00f4le croissant des donn\u00e9es en vie r\u00e9elle<\/strong>\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">Les essais cliniques apportent des r\u00e9ponses scientifiques essentielles, mais par nature, ils ne peuvent pas refl\u00e9ter pleinement la r\u00e9alit\u00e9 du quotidien des patients\u202f: la diversit\u00e9\u00a0des parcours, la complexit\u00e9\u00a0des maladies et l\u2019impr\u00e9visibilit\u00e9\u00a0des prises en charge.\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">Les donn\u00e9es en vie r\u00e9elle\u00a0contribuent \u00e0\u00a0combler cet \u00e9cart. Elles rendent compte de ce qui compte r\u00e9ellement pour les\u00a0personnes concern\u00e9es\u202f: l\u2019efficacit\u00e9\u00a0d\u2019un traitement sur la dur\u00e9e, sa tol\u00e9rance au quotidien et\u00a0sa place\u00a0dans la\u00a0vie r\u00e9elle\u00a0avec\u00a0la\u00a0maladie. En investissant dans des programmes solides de RWE, nous approfondissons notre compr\u00e9hension des besoins des patients, mesurons l\u2019impact r\u00e9el de nos m\u00e9dicaments et veillons\u00a0\u00e0\u00a0ce qu\u2019ils continuent d\u2019apporter des b\u00e9n\u00e9fices\u00a0concrets\u00a0aux personnes qui en d\u00e9pendent.\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\"><strong>Analyses\u00a0post<\/strong>\u2011<strong>hoc\u00a0et essais de phase<\/strong><strong>\u202f<\/strong><strong>IV<\/strong><strong>\u202f<\/strong><strong>: approfondir la compr\u00e9hension l\u00e0\u00a0c\u2019est essentiel<\/strong>\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">Les analyses\u00a0post\u2011hoc\u00a0et les \u00e9tudes de phase\u202fIV\u00a0\u2014\u00a0r\u00e9alis\u00e9es\u00a0apr\u00e8s l\u2019autorisation d\u2019un m\u00e9dicament\u00a0\u2014\u00a0jouent un r\u00f4le tout aussi\u00a0fondamental.\u00a0En tenant compte de\u00a0la diversit\u00e9\u00a0des patients et la variabilit\u00e9\u00a0des parcours de soins, nous questionnons\u00a0des\u00a0hypoth\u00e8ses afin\u00a0d\u2019en tirer\u00a0des enseignements\u00a0adapt\u00e9s aux\u00a0d\u00e9fis du monde r\u00e9el.\u00a0<br>Quel est l\u2019impact de nos m\u00e9dicaments chez des patients pr\u00e9sentant certaines comorbidit\u00e9s ou recevant d\u2019autres traitements\u202f? Quels marqueurs cliniques pourraient m\u00e9riter une exploration approfondie\u202f? Comment\u00a0l\u2019environnement\u00a0th\u00e9rapeutique, et par cons\u00e9quent les recommandations de traitement,\u00a0\u00e9voluent\u2011ils\u00a0au fil du temps\u202f?\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">En adoptant une approche cibl\u00e9e, nous concevons des analyses capables de r\u00e9pondre aux questions les plus\u00a0importantes\u00a0pour les\u00a0professionnels de sant\u00e9\u00a0comme pour les patients,\u00a0contribuant ainsi \u00e0 une meilleure compr\u00e9hension de la maladie et \u00e0 une prise en charge toujours plus individualis\u00e9e.\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\"><strong>Un avenir fond\u00e9 sur l\u2019apprentissage continu<\/strong>\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">Les enseignements issus des donn\u00e9es en vie r\u00e9elle, combin\u00e9s \u00e0 la\u00a0richesse\u00a0des essais de phase\u202fIV et des analyses\u00a0post\u2011hoc, offrent une compr\u00e9hension multidimensionnelle et\u00a0approfondie\u00a0de l\u2019impact d\u2019un m\u00e9dicament. Pour Ipsen, la g\u00e9n\u00e9ration\u00a0en continue\u00a0de donn\u00e9es apr\u00e8s\u00a0l\u2019autorisation\u00a0de mise sur le march\u00e9\u00a0n\u2019est pas\u00a0un simple compl\u00e9ment\u202f: c\u2019est un engagement. Un engagement\u00a0\u00e0\u00a0comprendre\u00a0pleinement\u00a0l\u2019impact de nos m\u00e9dicaments, non seulement pour le plus grand nombre, mais aussi pour chaque individu,\u00a0avec ses particularit\u00e9s, qui m\u00e9rite des r\u00e9ponses\u00a0\u00e0 ses questions.\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">L\u2019avenir de la prise en charge des patients reposera sur cette culture de l\u2019apprentissage continu. L\u2019autorisation d\u2019un m\u00e9dicament est une \u00e9tape importante,\u00a0qui m\u00e9rite\u00a0d\u2019\u00eatre c\u00e9l\u00e9br\u00e9e, mais elle ne marque pas la fin du parcours. Chaque donn\u00e9e issue du monde r\u00e9el, chaque r\u00e9sultat \u00e0 long terme, chaque analyse\u00a0post\u2011autorisation\u00a0nous rapproche\u00a0d\u2019une optimisation des soins\u00a0pour les patients qui en ont le plus besoin.\u00a0<\/p>\n\n<p class=\"heading-para wp-block-paragraph\">Notre ambition est claire\u202f: faire en sorte que le progr\u00e8s scientifique ne s\u2019arr\u00eate pas\u00a0\u00e0\u00a0l\u2019autorisation, mais\u00a0qu\u2019il s\u2019acc\u00e9l\u00e8re\u00a0gr\u00e2ce \u00e0 elle\u00a0\u2014\u00a0afin que chaque patient b\u00e9n\u00e9ficie non seulement\u00a0d\u2019une innovation th\u00e9rapeutique,\u00a0qui continue d\u2019\u00e9voluer\u00a0gr\u00e2ce \u00e0\u00a0de\u00a0nouvelles donn\u00e9es,\u00a0une approche cibl\u00e9e\u00a0et\u00a0une raison d\u2019\u00eatre.\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p>Par Sandra Silvestri, pour Ipsen.com\u00a0 Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que<\/p>\n","protected":false},"author":11,"featured_media":105613,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[81827],"tags":[],"class_list":["post-105617","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science-2","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0 - Global<\/title>\n<meta name=\"description\" content=\"Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0 - Global\" \/>\n<meta property=\"og:description\" content=\"Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-28T06:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1082\" \/>\n\t<meta property=\"og:image:height\" content=\"620\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"heloisedetouchet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"heloisedetouchet\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/\"},\"author\":{\"name\":\"heloisedetouchet\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/person\\\/2c275168b31beee81688f3c041877318\"},\"headline\":\"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0\",\"datePublished\":\"2026-05-28T06:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/\"},\"wordCount\":836,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Sandras-Photo.jpg\",\"articleSection\":[\"Science\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/\",\"name\":\"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0 - Global\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Sandras-Photo.jpg\",\"datePublished\":\"2026-05-28T06:00:00+00:00\",\"description\":\"Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Sandras-Photo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Sandras-Photo.jpg\",\"width\":1082,\"height\":620},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/actualites\\\/science-2\\\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Ipsengroup\",\"https:\\\/\\\/x.com\\\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/person\\\/2c275168b31beee81688f3c041877318\",\"name\":\"heloisedetouchet\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g\",\"caption\":\"heloisedetouchet\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0 - Global","description":"Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/","og_locale":"fr_FR","og_type":"article","og_title":"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0 - Global","og_description":"Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0","og_url":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/","og_site_name":"Global","article_published_time":"2026-05-28T06:00:00+00:00","og_image":[{"width":1082,"height":620,"url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg","type":"image\/jpeg"}],"author":"heloisedetouchet","twitter_card":"summary_large_image","twitter_creator":"@ipsengroup","twitter_site":"@ipsengroup","twitter_misc":{"Written by":"heloisedetouchet","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/"},"author":{"name":"heloisedetouchet","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/2c275168b31beee81688f3c041877318"},"headline":"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0","datePublished":"2026-05-28T06:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/"},"wordCount":836,"publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg","articleSection":["Science"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/","url":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/","name":"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0 - Global","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg","datePublished":"2026-05-28T06:00:00+00:00","description":"Dans un\u00a0environnement\u00a0th\u00e9rapeutique en constante \u00e9volution, l\u2019autorisation d\u2019un m\u00e9dicament ne constitue plus\u00a0la fin du\u00a0parcours:\u00a0ce n\u2019est que le\u00a0d\u00e9but. Les donn\u00e9es en vie r\u00e9elle (real\u2011world\u00a0evidence, RWE), les analyses\u00a0post\u2011hoc\u00a0et les\u00a0\u00e9tudes de phase\u202fIV structur\u00e9es ouvrent de nouvelles perspectives\u00a0pour l\u2019apprentissage scientifique.\u00a0","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#primaryimage","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg","width":1082,"height":620},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/actualites\/science-2\/pourquoi-les-donnees-obtenues-apres-autorisation-de-mise-sur-le-marche-redefinissent-lavenir-de-la-prise-en-charge-des-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"Pourquoi les donn\u00e9es\u00a0obtenues\u00a0apr\u00e8s\u00a0autorisation\u00a0de mise sur le march\u00e9\u00a0red\u00e9finissent l\u2019avenir de la prise en charge des patients\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/2c275168b31beee81688f3c041877318","name":"heloisedetouchet","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a294050dc7df14814ce352dcd30bd2b11c1bf6f269c4edf2111b59216f02bb15?s=96&d=mm&r=g","caption":"heloisedetouchet"}}]}},"jetpack_featured_media_url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2026\/05\/Sandras-Photo.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/105617","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/comments?post=105617"}],"version-history":[{"count":1,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/105617\/revisions"}],"predecessor-version":[{"id":105618,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/posts\/105617\/revisions\/105618"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media\/105613"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=105617"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/categories?post=105617"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/tags?post=105617"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}